Event Information

PSMA PET/CT Beyond the Images: The Imager’s and Clinician's Perspective



Display Date
Monday May 30, 2022 // 14:00-15:30 PT • 17:00-18:30 ET •  18:00-19:30 AT


1.5 Section 1 Group Learning Credits
Event Description

 [scroll down to register] 

Program Chair: 
Bobby Shayegan | Chair, CUA Guidelines Committee

Update of the Canadian Landscape

Invited Speakers & Canadian Guideline Authors:
Katherine Zukotynski | Associate Professor, McMaster University

Technology introduction

Frédéric Pouliot | Associate Professor, Université Laval

What we know and do not know from prospective PSMA imaging trials and the impact on outcomes

Featured Guest Speaker:
Stefano Fanti
Professor of Diagnostic Imaging
Director, Nuclear Medicine Division and PET Unit, The Policlinico S. Orsola, 
Director, Specialty School of Nuclear Medicine, University of Bologna

Imaging and RLT context in Europe

Special Guests:

Rebecca Lo bue
General Manager, Oncidium foundation

Introducing the Oncidium foundation: Supporting the development of radiotheranostics for cancer care to enhance patient access, globally

Odile Jaume
CEO, ICPO Foundation

Improve Education and Infrastructure, Expand Patient Access to Theranostics in Precision Oncology


•    describe the several PSMA-targeting tracers and PET/CT technology (SUVmax, SUVmean, etc.)
•    describe the accuracy of PSMA-PET/CT for staging and re-staging prostate cancer based on best prospective studies
•    understand the basis of PSMA radioligand therapy and the trials in metastatic prostate cancers
Supported by:
The ICPO FoundationThe Oncidium Foundation

image image